AI & Machine Learning Startups
32,327 companies tagged AI & Machine Learning, with their investors and founders.
Geneyx offers a genomic data analysis platform for secondary and tertiary interpretation of NGS data, including exome, whole genome sequencing, and gene panels, with AI/ML-driven variant interpretation, automated annotation, and customizable reporting. It serves genetics labs, life-science companies, clinical researchers, and research institutes worldwide, integrating with LIMS and existing bioinformatic pipelines.
1 investor
GenGenAI builds domain-specific generative AI that creates synthetic training data and annotations for vision AI models, addressing data scarcity for scenarios that are rare or costly to capture in the real world. It targets domains including autonomous driving, defense, surveillance, and home electronics.
1 investor
AI platform that converts a photo of an existing menu into a digital menu with automatic translation into 11 languages, QR ordering, and POS integration for small restaurant owners. It also offers AI food-image generation, trade-area/sales analytics, and a conversational AI assistant for menu management, targeting independent food-and-beverage businesses in South Korea.
1 investor
Genie is a personalized AI assistant that draws on a user's memories, tastes, social connections, and other apps to deliver contextual recommendations, such as places to visit or activities suited to the individual. It serves consumers looking for tailored suggestions based on their personal context.
1 investor
Genie is an AI data analyst that lets business users query and visualize their data in natural language without writing SQL, connecting to files, databases, or APIs through workspaces like Slack, Teams, or WhatsApp. It offers self-hosted, SOC2 Type 2-compliant deployments with locally-run LLMs so enterprises can keep internal data on their own infrastructure.</parameter> <parameter name="founders">[]
1 investor
Genie provides an AI platform for producing LiveOps, marketing, and social content that stays on brand, replacing brief decks, generators, editors, resizers, and localization passes. It targets teams shipping game events and marketing campaigns, positioning itself as a tool to speed up art pipelines and asset production.
1 investor
Genius AI builds autonomous AI software that handles the administrative work of service businesses — such as lead follow-up, payments, and rebooking — for owners and practitioners who care for clients. The system learns an owner's voice and standards to run these tasks automatically so they can focus on client care.
1 investor
Genki Robotics develops humanoid robotic systems built on physical AI, combining intelligence, dexterity, and resilience for use in public safety, urban maintenance, and other mission-driven environments. The company aims to integrate intelligent humanoids into society to augment human capability.
1 investor
GenoGra develops a pangenomic graph software platform for secondary genomic analysis, using graph-based modeling and hardware acceleration to detect complex and structural variants that linear reference methods miss. It targets researchers and organizations working in population genomics and genomic interpretation.
1 investor
Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.
1 investor
GenomeMiner develops A.I.-driven bioinformatics and genome mining software, using DNA sequencing and proprietary data from organisms in subtropical Okinawa to identify and produce valuable natural products. Originally founded as Tupac.Bio building tools for synthetic biology companies, it aims to serve the biotech industry and eventually develop its own end-products.
1 investor
Genomic Vision is a genome analysis company whose Molecular Combing technology characterizes DNA at single-molecule resolution for quality control in bioproduction and cell and gene therapy, as well as for drug discovery research. It serves pharmaceutical, biotech, and research organizations developing gene therapies and studying DNA replication.
1 investor
Genomiki develops AI/ML- and genomics-driven diagnostic, screening, and microbiome analysis tools that convert sequencing and clinical data into insights for early risk detection and personalized interventions. Its solutions are designed to integrate into clinical and wellness workflows to support medical decisions and research.
1 investor
GenMedPro is a genetics-based medication management platform that analyzes 26 genes to identify drug-drug and gene-drug interactions across a patient's entire medication regimen. The platform serves healthcare providers and care teams to reduce prescribing errors, prevent adverse events, and optimize medication safety for complex polypharmacy cases.
1 investor
Genopore is developing a single-molecule protein identification and quantitation system that uses chemo-selective protein labeling, solid-state nanopore translocation, and AI-powered optical readout to sequence whole proteins without mass spectrometry or affinity-based methods. It targets proteomics applications such as early disease detection, biomarker discovery, and drug discovery for the life sciences research market.
1 investor
Genova Diagnostics operates a clinical laboratory offering functional-medicine diagnostic tests, including gut microbiome, metabolomics, methylation, genomics, and oxidative stress panels. Its testing combines multiple technologies, including whole-genome shotgun sequencing with AI-based analysis, to help clinicians assess gut health and other physiological systems for personalized patient care.
1 investor
GenProof develops GenProof-1, a specialized large language model that automatically writes formal-verification proofs for source code, using the Isabelle prover to mathematically guarantee code correctness. It targets software developers seeking to verify code correctness rather than rely on testing.
1 investor
Genpulse builds AI infrastructure and purpose-built devices that capture health data and process it in real time to deliver insights to users and practitioners. It offers medical-grade AI diagnostic devices (for hair/scalp, skin, dental, eye, and gynecological analysis), white-label deployment, and APIs, SDKs, and medical AI datasets for building healthcare applications.
1 investor
Genrate.ai provides continuous monitoring of sales accounts, tracking leadership changes, strategic shifts, and competitive pressure that CRMs miss, then synthesizes these signals into prioritized insights. It is aimed at B2B sales teams to help them re-engage accounts and identify risks and opportunities.
1 investor
GenRocket provides an integrated platform that combines test data management with synthetic data generation, enabling enterprises to replace production data with secure, privacy-compliant synthetic alternatives for testing and AI/ML training. The platform progresses organizations through masking, subsetting, and design-driven synthetic data generation toward AI-orchestrated automation.
1 investor
GenScript Biotech is a life sciences company providing reagents, custom services, instruments, and biologics development solutions to research and pharmaceutical industries globally. The company operates through subsidiaries including Bestzyme (synthetic biology), ProBio (biologics CDMO), and GenScript Life Science Group, with manufacturing and R&D centers across China, Singapore, and the United States.
1 investor
GenText Group builds AI-powered writing tools for professionals including academics, legal professionals, and mental health practitioners. The company offers integrated solutions available both as standalone browser applications and as plugins for Microsoft Word.
1 investor
Gentle Energy Corporation provides knowledge and automated tools to optimize and reduce energy consumption, aiming to make energy use more efficient and environmentally friendly. The company positions its solutions as low-barrier services that operate with minimal resources.
1 investor
Tell If AI builds autonomous content systems for brands, leveraging deep learning and multimodal AI technologies.
1 investor











